Switzerland · Series A startup

Who invested in Neurosterix

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Pharma

Funding summaryUpdated 26 Oct 2026

$63Mraised across 1 round since 2024, from 1 source

Latest round
Series A, $63MApr 2024
Investors
1
See who backed them

The rounds

  1. Apr 2024
    Series A$63M

    Source recorded

Founders and team

From Neurosterix's own website: 1 founder, 1 on the team.

Fred CalloriCEO and Chairman, Co-Founder
  • Lisa CoreyVP of Clinical Operations

Everyone who backed them

Perceptive AdvisorsAsset manager1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Neurosterix

Who invested in Neurosterix?

Neurosterix's investors include Perceptive Advisors.

How much has Neurosterix raised?

Neurosterix has raised $63M across 1 round since 2024.

When did Neurosterix last raise?

Neurosterix's most recent round was a Series A of $63M in Apr 2024.

What was Neurosterix's biggest round?

Its most recent round, $63M in Apr 2024, is also its largest on record.

Who backed Neurosterix first?

Neurosterix's first round on record, in Apr 2024, was backed by Perceptive Advisors.

What stage is Neurosterix at?

Neurosterix's latest named round is a Series A, in Apr 2024.

Where is Neurosterix based?

Neurosterix is based in Switzerland.

Companies like Neurosterix

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.